Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Laura van ’t Veer
Heterogeneous Drug Penetrance of Veliparib and Carboplatin Measured in Triple Negative Breast Tumors
Breast Cancer Research
Cancer Research
Oncology
Related publications
Cisplatin Versus Carboplatin in Combination With Paclitaxel as Neoadjuvant Regimen for Triple Negative Breast Cancer
OncoTargets and Therapy
Oncology
Pharmacology
Advances in Small-Molecule Drug Discovery for Triple-Negative Breast Cancer
Future Medicinal Chemistry
Drug Discovery
Molecular Medicine
Pharmacology
Triple-Negative Breast Cancer
Prevalence of Papillomaviruses, Polyomaviruses, and Herpesviruses in Triple-Negative and Inflammatory Breast Tumors From Algeria Compared With Other Types of Breast Cancer Tumors
PLoS ONE
Multidisciplinary
Genes Associated With Histopathologic Features of Triple Negative Breast Tumors Predict Molecular Subtypes
Breast Cancer Research and Treatment
Cancer Research
Oncology
TBCRC 001: Randomized Phase II Study of Cetuximab in Combination With Carboplatin in Stage IV Triple-Negative Breast Cancer
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Current Perspectives on Genotype Classification and Individualized Drug Targeting in Triple-Negative Breast Cancer
Tropical Journal of Pharmaceutical Research
Pharmacology
Pharmaceutical Science
Pathological Response in a Triple Negative Breast Cancer Cohort Treated With Neoadjuvant Carboplatin and Docetaxel According to Lehmann's Refined Classification
Clinical Cancer Research
Cancer Research
Oncology
miR-134 in Extracellular Vesicles Reduces Triple-Negative Breast Cancer Aggression and Increases Drug Sensitivity
Oncotarget
Oncology
